DNA

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness MonthMainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

Updated Screening Guidelines Ensure Broader Access to Colorectal Cancer Screening in GermanyBERKELEY, Calif. and MAINZ, Germany, Feb. 11, 2025 (GLOBE…

2 months ago
IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer 

IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer 

Dr. Faller joins IMUNON with more than 30 years of industry, academic and laboratory experience, with specialized expertise in oncology…

2 months ago
Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceRecludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Recludix Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets…

2 months ago
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 

STAFFORD, Texas, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

2 months ago
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

3E10 vg/eye achieved an 83% reduction in injection burden vs. projected on-label aflibercept 2 mg Q8W, 70% required 0-1 supplemental…

2 months ago
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference SeriesGinkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

Evolution of Ferment conference to kick off Summer 2025 BOSTON, Feb. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is…

2 months ago
Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery ProgramRakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program

Rakovina Therapeutics Announces Additional Synthesized Compounds in its AI-Driven Cancer Drug Discovery Program

VANCOUVER, British Columbia, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing…

2 months ago
DIGITAL celebrates continued investments in Canadian genomicsDIGITAL celebrates continued investments in Canadian genomics

DIGITAL celebrates continued investments in Canadian genomics

VANCOUVER, BC, Feb. 5, 2025 /CNW/ - DIGITAL, Canada's Global Innovation Cluster for digital technologies, is celebrating its ongoing impact…

2 months ago
UMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testingUMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testing

UMC Utrecht adopts Volta Labs Callisto Sample Prep System to process thousands of samples for Whole Genome Sequencing-based prenatal and postnatal testing

BOSTON, Feb. 5, 2025 /PRNewswire/ -- Volta Labs, a leading genomics applications company, and UMC Utrecht, one of the largest public…

2 months ago
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology PanelsAkoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE…

2 months ago